Notably, alternative endeavors like MGL S3, a genetically engineered protein formed by combining MGL with an epidermal growth factor (EGF)-like peptide, bind directly to cancer cells, inhibiting their proliferation and enhancing their sensitivity to EGFR inhibitors [163,164]. Here, EGF is linked to cancer.